[Eligibles]
Adults and children over two years of age.
[Function and use]
The vaccine is indicated for active immunization against invasive meningococcal disease caused by epidemic Neisseria meningitidis serogroups A,C,Y,W135.
[Description]
The vaccine is a preparation of preparation polysaccharide antigens extracted from the culture of Neisseria meningitidis group ACYW135 respectively and Iyophilized after addition of an appropriate stabilizer. The final product looks like a white crisp cake. It shall dissolve in the accompanying Phosphate buffered saline (PBS) immediately, and turn into a clear liquid after reconstitution.
Active constituent: Neisseria meningitidis group ACYW135 capsular polysaccharides.
Subsidiary materials: All the components of subsidiary materials approved shall be listed.
Vaccine diluent: Sterile, pyrogen-free PBS.
1.Group ACYW135
2.Group A+C
3.prevent epidemic cerebrospinal meningitis
4.purified capsular polysaccharide antigens
Meningococcal Polysaccharide Vaccine
Meningococcal Polysaccharide Vaccine,Meningococcal Polysaccharide,Meningococcal Vaccine,Lyophilized Dosage Form Vaccine
Changchun Changsheng Life Sciences Ltd. , http://www.ccls-vaccine.com